Mesa Laboratories, Inc. (MLAB): Price and Financial Metrics

Mesa Laboratories, Inc. (MLAB)

Today's Latest Price: $277.37 USD

0.89 (-0.32%)

Updated Oct 23 4:00pm

Add MLAB to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 142 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

MLAB Stock Summary

  • MLAB's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 1,127.42 -- higher than 96.87% of US-listed equities with positive expected earnings growth.
  • With a year-over-year growth in debt of 616.55%, Mesa Laboratories Inc's debt growth rate surpasses 96.95% of about US stocks.
  • The volatility of Mesa Laboratories Inc's share price is greater than that of only 4.68% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to Mesa Laboratories Inc, a group of peers worth examining would be AMRN, SLP, TECH, ATRS, and SPSC.
  • MLAB's SEC filings can be seen here. And to visit Mesa Laboratories Inc's official web site, go to

MLAB Stock Price Chart Interactive Chart >

Price chart for MLAB

MLAB Price/Volume Stats

Current price $277.37 52-week high $288.80
Prev. close $278.26 52-week low $181.90
Day low $275.56 Volume 14,200
Day high $279.39 Avg. volume 39,662
50-day MA $254.29 Dividend yield 0.23%
200-day MA $240.90 Market Cap 1.42B

Mesa Laboratories, Inc. (MLAB) Company Bio

Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products. It operates through three segments: Instruments, Biological Indicators, and Continuous Monitoring. The company was founded in 1982 and is based in Lakewood, Colorado.

MLAB Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$277.37$133.01 -51%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Mesa Laboratories Inc. To summarize, we found that Mesa Laboratories Inc ranked in the 30th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of Mesa Laboratories Inc, consider:

  • The business' balance sheet reveals debt to be 10% of the company's capital (with equity being the remaining amount). Approximately merely 23.59% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
  • The weighted average cost of capital for the company is 9. This value is greater than 72.86% stocks in the Technology sector that generate free cash flow.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

COHR, IIVI, OMCL, TTGT, and ASML can be thought of as valuation peers to MLAB, in the sense that they are in the Technology sector and have a similar price forecast based on DCF valuation.

MLAB Latest News Stream

Event/Time News Detail
Loading, please wait...

MLAB Latest Social Stream

Loading social stream, please wait...

View Full MLAB Social Stream

Latest MLAB News From Around the Web

Below are the latest news stories about Mesa Laboratories Inc that investors may wish to consider to help them evaluate MLAB as an investment opportunity.

Mesa Laboratories declares $0.16 dividend

Mesa Laboratories (MLAB) declares $0.16/share quarterly dividend, in line with previous.Forward yield 0.25%Payable Dec. 15; for shareholders of record Nov. 30; ex-div Nov. 27.See MLAB Dividend Scorecard, Yield Chart, & Dividend Growth....

Seeking Alpha | October 1, 2020

Mesa Laboratories EPS misses by $0.11, misses on revenue

Mesa Laboratories (MLAB): Q1 Non-GAAP EPS of $1.67 misses by $0.11; GAAP EPS of $0.22 misses by $0.17.Revenue of $29.94M (+13.9% Y/Y) misses by $2.4M.Press Release...

Seeking Alpha | August 6, 2020


Lakewood, CO, July 06, 2020 (GLOBE NEWSWIRE) -- - Mesa Laboratories, Inc. (MLAB) (we, us, our, “Mesa Labs” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. Mesa Labs is a global technology innovator committed to solving some of the most critical quality control challenges in the pharmaceutical, healthcare, industrial safety, environmental and food and beverage industries. Mesa Labs offers products and services through four divisions (Sterilization and Disinfection Control, Biopharmaceutical Development, Instruments and Continuous Monitoring) to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world.

Yahoo | July 6, 2020

Mesa Laboratories, Inc. Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock in Public Offering

Source: Mesa Laboratories, Inc. – June 16, 2020 11:30 AM ET Lakewood, Colo., June 16, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc….

GlobeNewswire | June 16, 2020

Hedge Funds Aren’t Crazy About Mesa Laboratories, Inc. (MLAB) Anymore

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn't the intention, these filings to a certain extent level the playing field for ordinary

Yahoo Finance | June 14, 2020

Read More 'MLAB' Stories Here

MLAB Price Returns

1-mo 13.35%
3-mo 19.64%
6-mo 15.71%
1-year 24.66%
3-year 80.49%
5-year 150.46%
YTD 11.43%
2019 20.01%
2018 68.27%
2017 1.74%
2016 24.12%
2015 29.59%

MLAB Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full MLAB Dividend History

Continue Researching MLAB

Here are a few links from around the web to help you further your research on Mesa Laboratories Inc's stock as an investment opportunity:

Mesa Laboratories Inc (MLAB) Stock Price | Nasdaq
Mesa Laboratories Inc (MLAB) Stock Quote, History and News - Yahoo Finance
Mesa Laboratories Inc (MLAB) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9606 seconds.